echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Nat Commun: Comprehensive pharmacogenomics reveals subtype-specific treatment response for nasopharyngeal carcinoma

    Nat Commun: Comprehensive pharmacogenomics reveals subtype-specific treatment response for nasopharyngeal carcinoma

    • Last Update: 2021-05-31
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Nasopharyngeal carcinoma (NPC), as a malignant head and neck cancer, has a high incidence and usually occurs in certain regions, including Southeast Asia, North Africa, southern China, Hong Kong and Taiwan.


    Nasopharyngeal carcinoma (NPC), as a malignant head and neck cancer, has a high incidence.


    NPC involves many risk factors, including environmental factors, EBV (Epstein-Barr virus) infection , smoking, diet and personal living habits.


    infection

    Genomic variation and family risk are another important cause of nasopharyngeal cancer .


    Genomic variation and family risk are another important cause of nasopharyngeal cancer.



    Histological and molecular landscape of nasopharyngeal carcinoma subtypes

    Histological and molecular landscape of nasopharyngeal carcinoma subtypes

    In this study, researchers through integrated pharmacogenomics analysis found that NPC subtypes maintain unique molecular characteristics, drug responsiveness and graded radiosensitivity.




    CRT Screening Reveals Combination Therapy Can Improve Treatment Effect

    CRT Screening Reveals Combination Therapy Can Improve Treatment Effect

    All in all, the results of this study provide a personalized and precise oncology example that guides the treatment strategy of NPC subtypes through the application of comprehensive pharmacogenomics methods.


    The results of this study provide a personalized and precise oncology example that guides the treatment strategy of NPC subtypes through the application of comprehensive pharmacogenomics methods.



    org/10.




    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.